Gland Pharma's JNPC facility completes USFDA inspection
Form 483 Observations. These observations are procedural in nature. The corrective and preventive actions for these observations will be submitted to the US FDA within the stipulated period. The ...
Hosted on MSN12m
FDA OKs adaptive brain pacemaker for Parkinson's treatment
The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...
Hosted on MSN17m
With RFK Jr. in Charge, Supplement Makers See Chance To Cash In
The FDA is already limited in policing claims of health benefits by makers of supplements and herbal remedies — a $70 billion ...
cnbctv1850m
Gland Pharma's Visakhapatnam facility gets 3 observations after USFDA inspection
In a regulatory filing, Gland Pharma said, "...the United States Food and Drug Administration (USFDA) has conducted a ...
Gland Pharma's Visakhapatnam facility gets 3 USFDA observations
Gland Pharma has announced that the United States Food and Drug Administration (USFDA) conducted a Pre-Approval Inspection (PAI) for Sterile Active Pharmaceutical Ingredients (APIs) at its facility in ...
Letters: Gutting of federal health agencies has consequences for patients with chronic illnesses
How can these patients and millions of other Americans with all variety of illnesses ever dream of a cure or treatment now?